Xalkori
These highlights do not include all the information needed to use XALKORI safely and effectively. See full prescribing information for XALKORI. XALKORI (crizotinib) capsules, for oral useXALKORI (crizotinib) oral pelletsInitial U.S. Approval: 2011
2a51b0de-47d6-455e-a94c-d2c737b04ff7
HUMAN PRESCRIPTION DRUG LABEL
Nov 20, 2023
Pfizer Laboratories Div Pfizer Inc
DUNS: 134489525
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CRIZOTINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
CRIZOTINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
CRIZOTINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
CRIZOTINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
CRIZOTINIB
Product Details
FDA regulatory identification and product classification information